Hong Kong
# |
Name |
Price to Sales Ratio (P/S) |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
721.67 |
Jan. 14, 2025 | USD 0.13 | -1.02% |
|
Hong Kong |
|
2 |
102.90 |
Jan. 14, 2025 | USD 0.39 | 0.30% |
|
Hong Kong |
|
3 |
14.78 |
Jan. 14, 2025 | USD 0.26 | 2.03% |
|
Hong Kong |
|
4 |
8.92 |
Jan. 14, 2025 | USD 14.74 | 7.67% |
|
Hong Kong |
|
5 |
3.40 |
Jan. 14, 2025 | USD 0.83 | 3.07% |
|
Hong Kong |
|
6 |
2.77 |
Jan. 14, 2025 | USD 3.02 | 2.59% |
|
Hong Kong |
|
7 |
1.82 |
Jan. 14, 2025 | USD 0.37 | 1.03% |
|
Hong Kong |
|
8 |
1.56 |
Jan. 14, 2025 | USD 0.21 | 8.82% |
|
Hong Kong |
|
9 |
0.64 |
Jan. 13, 2025 | USD 0.10 | 0.02% |
|
Hong Kong |
The Biotechnology company in Hong Kong with the highest Price to Sales Ratio (P/S) is SinoMab BioScience Limited (HKSE: 3681.HK) at 721.67.
The Biotechnology company in Hong Kong with the lowest Price to Sales Ratio (P/S) is Yunnan Energy International Co. Limited (HKSE: 1298.HK) at 0.64.
The top 10 Biotechnology companies in Hong Kong by Price to Sales Ratio (P/S) are SinoMab BioScience Limited, Sirnaomics Ltd., KuangChi Science Limited, BeiGene, Ltd., Guangdong Hybribio Biotech Co.,Ltd., HUTCHMED (China) Limited, Sino Biopharmaceutical Limited, Frontage Holdings Corporation and Yunnan Energy International Co. Limited.
The bottom 10 Biotechnology companies in Hong Kong by Price to Sales Ratio (P/S) are Yunnan Energy International Co. Limited, Frontage Holdings Corporation, Sino Biopharmaceutical Limited, HUTCHMED (China) Limited, Guangdong Hybribio Biotech Co.,Ltd., BeiGene, Ltd., KuangChi Science Limited, Sirnaomics Ltd. and SinoMab BioScience Limited.